Clinical Trials

New Search
Title   A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Ustekinumab in Subjects With Active Systemic Lupus Erythematosus
Disease/Condition   Rheumatic Diseases,Dermatology,Pediatrics,Geriatrics,Lupus,Autoimmune Diseases
Eligibility Criteria   Click here for eligibility requirements
Principal Investigator   Chaim Putterman, MD
Contact Name   Nicole Jordan
Contact Email
IRB/Protocol Number   18-02-68-01E
Status   Active/Enrolling
Adult Clinical Trial   Yes
Pediatric Clinical Trial   Yes
Sub-Specialty   Rheumatology